Jin Zhou
West China Hospital · First Affiliated Hospital of Harbin Medical University · First affliliated hospital of Harbin medical university
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jin Zhou as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:06 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07191977 · Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell CarcinomaWest China Hospital · not yet recruiting · Esophageal Squamour Cell Cancer · principal investigator
- Ph1/Ph2NCT06753747 · A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell CarcinomaWest China Hospital · recruiting · Esophagus Cancer · principal investigator
- Ph1NCT06225921 · Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell CarcinomasWest China Hospital · unknown · Esophageal Squamous Cell Carcinoma · principal investigator
- Ph1NCT06109207 · Neoadjuvant Camrelizumab With Dalpiciclib for Resectable Head and Neck Squamous Cell CarcinomasWest China Hospital · unknown · Head and Neck Squamous Cell Carcinoma · principal investigator
- Ph3NCT03515018 · Evaluation of the Therapeutic Effect of HU Pulse Therapy for CML PatientsFirst Affiliated Hospital of Harbin Medical University · unknown · Leukemia, Chronic Myeloid · study chair
- N/ANCT03423706 · Clinical Studies of New Model Haploidentical Hematopoietic Stem Cell TransplantationFirst Affiliated Hospital of Harbin Medical University · unknown · CD19-chimeric Antigen Receptor T Cells, Relapsed and/or Refractory Acute Lymphoblastic Leukemia, the Haploidentical Hematopoietic Stem Cell Transplantation · study chair
- N/ANCT02991066 · Role of Microparticles in the Coagulopathy of Acute Promyelocytic LeukemiaFirst Affiliated Hospital of Harbin Medical University · unknown · Acute Promyelocytic Leukemia · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:06 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 68 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:06 UTC. The ranking covers the 200 most relevant of 1383 PubMed records, and a shared surname and initials can bring in a namesake. All 1383 on PubMed
- 496 citationsRCR 46.6
- 352 citationsRCR 16.2
- 306 citationsRCR 18.8
- Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial.Lancet Gastroenterol Hepatol · 2022265 citationsRCR 16.1
- 221 citationsRCR 22.1
- 217 citationsRCR 18.3
- First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC.N Engl J Med · 2023214 citationsRCR 16.0
- 208 citationsRCR 20.3
- Icotinib versus chemotherapy as adjuvant treatment for stage II-IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial.Lancet Respir Med · 2021167 citationsRCR 7.3
- 165 citationsRCR 11.7